New & Noteworthy

Oct 17, 2017
Pharmaceutical Executive
Today’s model requires a fourth partner—the systems integrator, writes Adam Nelson.
Oct 10, 2017
Pharmaceutical Executive
European Commission talks drug industry investment, health issues during State of the Union.
Oct 09, 2017
Pharmaceutical Executive
What is the true potential of real-world evidence studies and what are the right questions to ask in determining product performance in the marketplace?
Oct 06, 2017
TESARO president and COO Mary Lynne Hedley talks about responsible drug development and commercialization, and the practical dimension of putting patients first.
Oct 03, 2017
With the NASH pipeline filling up fast, Mariel Metcalfe looks at what pharma companies need to do to ensure their products do not end up as also-rans in this dynamic new market segment.
Oct 03, 2017
Jayachandra Reddy and Rishit Thakkar discuss the challenges facing early entrants in the Non-alcoholic Steatohepatitis market.
Oct 02, 2017
Jackie Ilacqua & Valerie Wriede trace the evolution of cancer treatment and drill down into the latest developments currently redefining the landscape, together with those on the horizon.
Sep 22, 2017
Pharmaceutical Executive
Our latest review reveals that those companies scoring well on profit management metrics are best positioned to maintain that crucial edge in performance execution.
Sep 21, 2017
Pharmaceutical Executive
Can the pharma industry truly achieve a patient-centric supply chain? How some clinical trial logistics companies are racing ahead in making the patient a key link in the chain.
Sep 15, 2017
Pharmaceutical Executive
Technology and other trends in medicine are driving the need for new strategies and investments in temperature sensitive packaging.
native1_300x100
lorem ipsum